ZIMMER BIOMET HOLDINGS, INC. (ZBH)
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE
$100.74
+1.60%
Investingg Score
51.4 / 100
Hold
Business overview
- Gross margin of 69.7%
- Operating margin of 13.3%
- Revenue growth YoY of 7.2%
The company benefits from high profitability on sales, yet operating efficiency and growth are only modest.
Financial health
- Free cash flow margin of 17.9%
- EV/EBITDA of 2.59
- Balance Sheet score of 50
Cash generation is solid and the low EV/EBITDA suggests cheap valuation, while the balance‑sheet strength is average.
- Gross Margin
- 69.7%
- Operating Margin
- 13.3%
- Current Ratio
- 2.0x
- Debt / Equity
- 0.55
- Free Cash Flow (TTM)
- $1.5B
- Interest Coverage
- 4x
Valuation
- Forward P/E ratio of 10.82
- EV/EBITDA of 2.59
- P/E ratio unavailable (Data unavailable)
Forward multiples appear cheap, yet the lack of a current P/E adds uncertainty to the valuation picture.
- P/E (TTM)
- Data unavailable
- Forward P/E
- 10.8x
- Price / Sales
- 0.0x
- EV / EBITDA
- 2.6x
- FCF Yield
- Data unavailable
Key risks
- Declining earnings per share
- Missing current P/E and market cap data create valuation uncertainty
Market cap $0 · data as of 2026-08-20
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze ZBH with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.